Loading financials from SEC filings…
Software - Application · Technology · Fiscal year ends Dec 31
Teradata reported revenue of $1.7B in the fiscal year ended Dec 2025, down 5.0% from the year before. Operating income was $205M, an operating margin of 12.3%, and net income was $130M. Operating cash flow of $305M less capital expenditure of $19M left free cash flow of $286M. It held more cash than debt (net cash $37M).
Ranks among the 83 software - application companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.
Last 5 fiscal years
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1,917 | 1,795 | 1,833 | 1,750 | 1,663 |
| Cost of revenue | 731 | 714 | 718 | 692 | 676 |
| Gross profit | 1,186 | 1,081 | 1,115 | 1,058 | 987 |
| Research & development | 309 | 313 | 294 | 284 | 280 |
| Selling, general & admin | 646 | 650 | 635 | 565 | 502 |
| Operating income | 231 | 118 | 186 | 209 | 205 |
| Interest expense | 26.0 | 24.0 | 30.0 | 29.0 | 26.0 |
| Pre-tax income | 192 | 67.0 | 117 | 164 | 178 |
| Income tax | 45.0 | 34.0 | 55.0 | 50.0 | 48.0 |
| Net income | 147 | 33.0 | 62.0 | 114 | 130 |
| Diluted EPS | 1.30 | 0.31 | 0.61 | 1.16 | 1.35 |
| Diluted shares | 113 | 106 | 102 | 98.2 | 96.6 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | 592 | 569 | 486 | 420 | 493 |
| Receivables | 336 | 364 | 286 | 234 | 251 |
| Inventory | 26.0 | 8.0 | 13.0 | 18.0 | 13.0 |
| Current assets | 1,106 | 1,028 | 869 | 749 | 837 |
| Net PP&E | 288 | 244 | 239 | 185 | 198 |
| Goodwill | 396 | 390 | 398 | 394 | 399 |
| Total assets | 2,169 | 2,022 | 1,873 | 1,704 | 1,779 |
| Payables | 67.0 | 94.0 | 100 | 106 | 96.0 |
| Deferred revenue | 552 | 589 | 570 | 512 | 533 |
| Current liabilities | 1,033 | 1,007 | 996 | 930 | 914 |
| Short-term debt | 88.0 | 0.0 | 19.0 | 25.0 | 25.0 |
| Long-term debt | 324 | 498 | 480 | 455 | 431 |
| Total liabilities | 1,709 | 1,764 | 1,738 | 1,571 | 1,549 |
| Shareholders' equity | 460 | 258 | 135 | 133 | 230 |
| Backlog (remaining obligations) | 2,629 | 2,400 | 2,681 | 2,301 | 2,182 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 463 | 419 | 375 | 303 | 305 |
| Capital expenditure | 28.0 | 14.0 | 19.0 | 24.0 | 19.0 |
| Free cash flow | 435 | 405 | 356 | 279 | 286 |
| Depreciation & amortisation | 149 | 134 | 116 | 100 | 90.0 |
| Stock-based compensation | 112 | 126 | 126 | 119 | 112 |
| Share buybacks | 244 | 387 | 308 | 215 | 140 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | −6.4% | 2.1% | −4.5% | −5.0% |
| Operating income growth (YoY) | – | −48.9% | 57.6% | 12.4% | −1.9% |
| EPS growth (YoY) | – | −76.2% | 96.8% | 90.2% | 16.4% |
| Gross margin | 61.9% | 60.2% | 60.8% | 60.5% | 59.4% |
| Operating margin | 12.1% | 6.6% | 10.1% | 11.9% | 12.3% |
| Net margin | 7.7% | 1.8% | 3.4% | 6.5% | 7.8% |
| Return on equityBlank when equity is negative | 32.0% | 12.8% | 45.9% | 85.7% | 56.5% |
| ROCEEBIT ÷ (assets − current liabilities) | 20.3% | 11.6% | 21.2% | 27.0% | 23.7% |
| Free cash flow margin | 22.7% | 22.6% | 19.4% | 15.9% | 17.2% |
| Cash conversion (CFO ÷ net income) | 3.15x | 12.7x | 6.05x | 2.66x | 2.35x |
| Receivable days | 64 | 74 | 57 | 49 | 55 |
| Inventory days | 13 | 4 | 7 | 9 | 7 |
| Payable days | 33 | 48 | 51 | 56 | 52 |
| Interest cover | 8.88x | 4.92x | 6.20x | 7.21x | 7.88x |
| Debt ÷ equity | 0.90x | 1.93x | 3.70x | 3.61x | 1.98x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | −180 | −71.0 | 13.0 | 60.0 | −37.0 |
| Current ratio | 1.07x | 1.02x | 0.87x | 0.81x | 0.92x |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.